查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1561649

免疫组织化学市场报告（按产品（抗体、设备、试剂、试剂盒）、应用（诊断、药物测试）、最终用途（医院和诊断实验室、研究机构等）和地区 2024-2032

Immunohistochemistry Market Report by Product (Antibodies, Equipment, Reagents, Kits), Application (Diagnostics, Drug Testing), End Use (Hospitals and Diagnostic Laboratories, Research Institutes, and Others), and Region 2024-2032
出版日期: | 出版商: IMARC | 英文 147 Pages | 商品交期: 2-3个工作天内

价格

2023年全球免疫组化市场规模达26IMARC Group美元。慢性病盛行率的上升、对个人化药物的需求不断增加、诊断技术的显着进步、医疗基础设施投资的增加以及人口老化的加剧是推动市场成长的一些主要因素。

免疫组织化学市场分析：

  • 主要市场驱动力：传染病和慢性病发病率不断上升，需要先进的诊断解决方案，这是市场的主要驱动力。很大程度上依赖生物标记识别的个人化医疗的广泛采用进一步刺激了对免疫组织化学的需求。诊断技术的重大技术进步提高了免疫组织化学测试的准确性和效率。
  • 主要市场趋势：先进成像技术的日益整合和自动化以提高诊断吞吐量和准确性是市场的主要趋势之一。伴随诊断和精准医学的日益转变强调个人化治疗策略。多重检测的不断发展允许同时检测多种生物标誌物，从而提高效率。
  • 地理趋势：北美占据免疫组织化学市场最大的地区。加拿大和美国对癌症研究和诊断进步的高度重视正在推动市场成长。这主要是由于大量的医疗保健支出和完善的医疗基础设施。个人化医疗和基于生物标记的测试的广泛采用，特别是在肿瘤学领域，正在推动整个地区的市场成长。
  • 竞争格局：免疫组织化学产业的一些主要市场参与者包括Abcam plc、安捷伦科技公司、Beckman Coulter Inc.（丹纳赫）、Becton Dickinson and Company、Bio SB Inc.、Bio-Rad Laboratories Inc.、Bio - Techne Corporation、Cell Signaling Technology Inc.、F. Hoffmann-La Roche AG、Merck KGaA、Perkinelmer Inc. 和 Thermo Fisher Scientific Inc. 等。
  • 挑战与机会：市场面临各种挑战，包括与先进成像系统和试剂相关的高成本、缺乏能够解释复杂免疫组化资料的熟练专业人员以及对产品审批的严格监管要求。然而，市场面临着一些机会，例如对个人化医疗和标靶疗法的需求不断增长，这些疗法严重依赖免疫组织化学标记来製定有效的治疗计划。

免疫组织化学市场趋势：

慢性病盛行率增加

包括癌症在内的慢性病发生率不断上升，推动了准确诊断和预后工具的需求。免疫组织化学对于检测癌症和其他疾病的生物标记至关重要，有助于精确的诊断和治疗计划。根据世界卫生组织（WHO）公布的资料，2022年估计将新增癌症病例2,000万例，死亡人数970万人。据估计，癌症诊断后 5 年内存活的人数为 5,350 万人。大约五分之一的人在一生中罹患癌症，大约九分之一的男性和十二分之一的女性死于疾病。主要参与者透过推出更有效的产品和服务来适当地应对这种激增。例如，2024 年 4 月，生命科学研究和临床诊断产品领域的全球领导者 Bio-Rad Laboratories, Inc. 宣布推出首款超灵敏多重数位 PCR 检测方法 ddPLEX ESR1 突变检测试剂盒。该检测扩展了该公司针对肿瘤市场的微滴数位 PCR (ddPCR) 产品，其中高灵敏度和多重突变检测检测有助于转化研究、治疗选择和疾病监测。预计这将进一步提高未来几年免疫组织化学市场的预测。

重大技术进步

显微镜、染色技术和数位成像方面不断发展的技术创新提高了免疫组织化学程序的有效性和效率，使其成为详细组织分析的首选方法。例如，2023 年5 月，全球领先的医疗技术公司BD（Becton Dickinson 公司）宣布在全球范围内商业推出一款新的世界销售分类仪器，该仪器提供两项突破性技术，使研究人员能够发现有关销售的更详细资讯以前在传统流式细胞术实验中是看不见的。借助 BD CellView 影像技术，研究人员可以看到单一细胞的详细显微影像，并根据视觉特征进行高速分类，以即时确认见解。借助 BD SpectalFX 技术，研究人员可以实现全光谱细胞分选，再加上新的模组化光学架构和系统感知演算法带来的扩展性能，从而在简化的工作流程中执行高参数实验。

日益关注个人化医疗

个人化医疗（尤其是肿瘤学）的日益转变，正在推动对免疫组织化学的需求，以识别特定的分子标靶并根据个别患者的情况量身定制治疗方案，从而改善治疗结果。例如，2023 年6 月，全球科学服务领导者赛默飞世尔科技(Thermo Fisher Scientific) 宣布推出Gibco OncoPro 肿瘤类培养基试剂盒，这是首款专为扩增患者来源的类肿瘤或癌症类器官而开发的市售培养基，来自多种癌症适应症。同样，2023 年 1 月，班加罗尔阿波罗癌症中心推出了印度首个人工智慧精准肿瘤中心 (POC)，这是一项重大倡议，将大幅提高肿瘤护理的品质。该中心将利用人工智慧提供的巨大可能性，帮助肿瘤学家、患者和照护者在有限的时间内获得最佳结果。这正在影响全球免疫组织化学市场的收入。

免疫组织化学市场细分：

IMARC Group提供了每个细分市场的主要趋势的分析，以及 2024-2032 年全球、区域和国家层面的预测。我们的报告根据产品、应用和最终用途对市场进行了分类。

按产品划分：

  • 抗体
    • 一抗
    • 二抗
  • 装置
    • 玻片染色系统
    • 组织微阵列
    • 组织处理系统
    • 玻片扫描仪
    • 其他的
  • 试剂
    • 组织学染色
    • 封闭血清和试剂
    • 显色底物
    • 固定试剂
    • 稳定剂
    • 有机溶剂
    • 蛋白水解酶
    • 稀释剂
  • 套件

抗体占大部分市场份额

该报告根据产品提供了详细的市场细分和分析。这包括抗体（初级和次级）、设备（玻片染色系统、组织微阵列、组织处理系统、玻片扫描仪等）、试剂（组织学染色剂、封闭血清和试剂、显色底物、固定试剂、稳定剂、有机溶剂、蛋白水解酶和稀释剂）和试剂盒。根据该报告，抗体代表了最大的部分。

对疾病诊断和研究的需求不断增长，特别是癌症和传染病，这提高了对特异性抗体的需求。抗体工程的不断创新提高了特异性和敏感性，从而提高了诊断准确性。不断扩大的生物医学研究需要多种抗体来进行详细的细胞和分子研究。个人化治疗方法需要精确的生物标记识别，从而促进标靶抗体的使用。例如，2023年8月，Regeneron Pharmaceuticals, Inc.宣布生物医学高级研究与开发（BARDA）机构已与Regeneron达成协议，支持下一代COVID-19单株抗体的临床开发、临床生产和监管许可流程用于预防SARS-CoV-2 感染的抗体疗法。

按应用划分：

  • 诊断
    • 癌症
    • 传染病
    • 心血管疾病
    • 自体免疫疾病
    • 糖尿病
    • 肾臟病
  • 药物检测

诊断占产业最大份额

报告还提供了基于应用程式的详细市场细分和分析。这包括诊断（癌症、传染病、心血管疾病、自体免疫疾病、糖尿病和肾臟疾病）和药物测试。报告称，诊断占据了最大的市场份额。

心血管疾病、传染病、癌症、自体免疫疾病、肾臟病和糖尿病病例的增加需要先进的诊断方法。与此一致的是，人们更加关注基于透过免疫组织化学检测到的特定生物标记的个人化治疗计划。染色技术和新兴技术的显着改进提高了疾病诊断的准确性和效率。不断增长的研究活动需要详细的细胞分析，促进免疫组织化学在理解疾病机制和病理学方面的应用。这进一步推动了免疫组织化学市场对诊断的需求成长。

按最终用途细分：

  • 医院和诊断实验室
  • 研究所
  • 其他的

医院和诊断实验室代表领先的细分市场

该报告根据最终用途对市场进行了详细的细分和分析。这包括医院和诊断实验室、研究机构等。根据该报告，医院和诊断实验室代表了最大的部分。

慢性病（尤其是癌症）发生率的上升推动了对免疫组织化学等精确诊断工具的需求，以准确识别和分类疾病状态。数位成像系统和染色技术的重大创新增强了免疫组织化学的诊断能力和通量，使其对临床环境更具吸引力。人们越来越关注诊断过程中遵守高品质和监管标准，因此需要免疫组织化学等可靠的技术。对医疗保健基础设施和诊断服务的投资不断增加，促进了已开发市场和新兴市场采用免疫组织化学等先进诊断方法。

按地区划分：

  • 北美洲
    • 美国
    • 加拿大
  • 亚太
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 印尼
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 其他的
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他的
  • 中东和非洲

北美市场领先，占据最大的免疫组化市场份额

该报告还对所有主要区域市场进行了全面分析，其中包括北美（美国和加拿大）；欧洲（德国、法国、英国、义大利、西班牙、俄罗斯等）；亚太地区（中国、日本、印度、韩国、澳洲、印尼等）；拉丁美洲（巴西、墨西哥等）；以及中东和非洲。报告称，北美是免疫组织化学最大的区域市场。

癌症和其他慢性病病例的增加推动了对免疫组织化学等精确诊断方法的需求，以识别有效治疗的生物标记物，这影响了整个地区的市场成长。完善的医疗设施和雄厚的研发资金（R&D）正在促进先进诊断技术的采用。根据美国国家医学图书馆的资料，预计2024年美国将新增2,001,140例癌症病例，611,720例癌症死亡。到 2021 年，癌症死亡率持续下降，自 1991 年以来，由于吸烟减少、某些癌症的早期检测以及辅助和转移治疗方案的改进，癌症死亡率避免了超过 400 万人死亡。

（请注意，这只是关键参与者的部分列表，报告中提供了完整列表。）

  • 该市场竞争激烈，安捷伦科技、赛默飞世尔科技和罗氏诊断等主要厂商占据主导地位。这些参与者专注于创新和策略合作伙伴关係，以增强其产品组合。 Merk Group、Bio-Rad Laboratories 和 Danaher Corporation 等其他重要公司强调透过合作和收购扩大其全球足迹。 2023 年 2 月，安捷伦科技公司推出了一款整合解决方案，将 xCELLigence RTCA HT 平台与 Bio Tek BioSpa 8 自动培养箱结合。这项新开发提供了更高水准的工作流程自动化，允许进一步创建用于免疫肿瘤学的无标记高通量效力测定以及针对疫苗市场的高通量病毒细胞病变效应（CPE）测定。

免疫组织化学市场新闻：

  • 2023 年 8 月，全球科技供应商丹纳赫签署了最终协议，以 57 亿美元的价格收购英国蛋白质耗材供应商 Abcam 的所有已发行股份。
  • 2024 年1 月，安捷伦科技公司宣布与Incyte 达成协议，该协议将汇集安捷伦在伴随诊断(CDx) 开发方面的专业知识和良好记录，以支持Incyte 血液学和肿瘤学产品组合商业化的发展。
  • 2022 年 6 月，领先的科技公司默克宣布与安捷伦科技公司合作，推动流程分析技术 (PAT)。 PAT 受到全球监管机构的大力鼓励，是即时发布和生物处理 4.0 的关键推动者。

本报告回答的关键问题：

  • 迄今为止，全球免疫组化市场表现如何，未来几年将如何表现？
  • 全球免疫组化市场的驱动因素、限制因素和机会是什么？
  • 每个驱动因素、限制因素和机会对全球免疫组织化学市场有何影响？
  • 主要区域市场有哪些？
  • 哪些国家代表了最具吸引力的免疫组织化学市场？
  • 基于产品的市场区隔是什么？
  • 免疫组化市场上最具吸引力的产品是什么？
  • 基于应用的市场区隔是什么？
  • 免疫组化市场中最具吸引力的应用是什么？
  • 根据最终用途分類的市场是怎样的？
  • 免疫组织化学市场中最具吸引力的最终用途是什么？
  • 市场竞争结构如何？
  • 全球免疫组化市场的主要参与者/公司有哪些？

本报告回答的关键问题：

  • 迄今为止，全球免疫组化市场表现如何，未来几年将如何表现？
  • 全球免疫组化市场的驱动因素、限制因素和机会是什么？
  • 每个驱动因素、限制因素和机会对全球免疫组织化学市场有何影响？
  • 主要区域市场有哪些？
  • 哪些国家代表了最具吸引力的免疫组织化学市场？
  • 基于产品的市场区隔是什么？
  • 免疫组化市场上最具吸引力的产品是什么？
  • 基于应用的市场区隔是什么？
  • 免疫组化市场中最具吸引力的应用是什么？
  • 根据最终用途分類的市场是怎样的？
  • 免疫组织化学市场中最具吸引力的最终用途是什么？
  • 市场竞争结构如何？
  • 全球免疫组化市场的主要参与者/公司有哪些？

目录

第一章：前言

第 2 章：范围与方法

  • 研究目的
  • 利害关係人
  • 数据来源
    • 主要来源
    • 二手资料
  • 市场预测
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第 3 章：执行摘要

第 4 章：简介

  • 概述
  • 主要行业趋势

第 5 章：全球免疫组织化学市场

  • 市场概况
  • 市场表现
  • COVID-19 的影响
  • 市场预测

第 6 章：市场区隔：依产品

  • 抗体
    • 市场趋势
    • 关键环节
      • 一抗
      • 二抗
    • 市场预测
  • 装置
    • 市场趋势
    • 关键环节
      • 玻片染色系统
      • 组织微阵列
      • 组织处理系统
      • 玻片扫描仪
      • 其他的
    • 市场预测
  • 试剂
    • 市场趋势
    • 关键环节
      • 组织学染色
      • 封闭血清和试剂
      • 显色底物
      • 固定试剂
      • 稳定剂
      • 有机溶剂
      • 蛋白水解酶
      • 稀释剂
    • 市场预测
  • 套件
    • 市场趋势
    • 市场预测

第 7 章：市场区隔：按应用

  • 诊断
    • 市场趋势
    • 关键环节
      • 癌症
      • 传染病
      • 心血管疾病
      • 自体免疫疾病
      • 糖尿病
      • 肾臟病
    • 市场预测
  • 药物检测
    • 市场趋势
    • 市场预测

第 8 章：市场区隔：最终用途别

  • 医院和诊断实验室
    • 市场趋势
    • 市场预测
  • 研究所
    • 市场趋势
    • 市场预测
  • 其他的
    • 市场趋势
    • 市场预测

第 9 章：市场区隔：按地区

  • 北美洲
    • 美国
    • 加拿大
  • 亚太
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 印尼
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 其他的
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他的
  • 中东和非洲
    • 市场趋势
    • 市场细分：按国家/地区
    • 市场预测

第 10 章：SWOT 分析

  • 概述
  • 优势
  • 弱点
  • 机会
  • 威胁

第 11 章：价值链分析

第 12 章：波特五力分析

  • 概述
  • 买家的议价能力
  • 供应商的议价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第 13 章：价格分析

第14章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • Abcam plc
    • Agilent Technologies Inc.
    • Beckman Coulter Inc. (Danaher Corporation)
    • Becton Dickinson and Company
    • Bio SB Inc.
    • Bio-Rad Laboratories Inc.
    • Bio-Techne Corporation
    • Cell Signaling Technology Inc.
    • F. Hoffmann-La Roche AG
    • Merck KGaA
    • Perkinelmer Inc.
    • Thermo Fisher Scientific Inc.
Product Code: SR112024A4404

The global immunohistochemistry market size reached US$ 2.6 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 4.9 Billion by 2032, exhibiting a growth rate (CAGR) of 6.8% during 2024-2032. The rising prevalence of chronic diseases, the increasing demand for personalized medicines, significant advancements in diagnostic techniques, growing investments in healthcare infrastructure, and the rising aging population are some of the major factors propelling the growth of the market.

Immunohistochemistry Market Analysis:

  • Major Market Drivers: The growing incidence of infectious and chronic diseases which necessitate advanced diagnostic solutions represent the major drivers of the market. The widespread adoption of personalized medicine, which relies heavily on biomarker identification is further stimulating the demand for immunohistochemistry. Significant technological advancements in diagnostic techniques enhance the accuracy and efficiency of immunohistochemistry tests.
  • Key Market Trends: The increasing integration and automation of advanced imaging technologies to enhance diagnostic throughput and accuracy represents one of the key trends in the market. The rising shift toward companion diagnostic and precision medicine, emphasizes personalized treatment strategies. The growing development of multiplex assays allows simultaneous detection of multiple biomarkers thus increasing efficiency.
  • Geographical Trends: North America accounts for the largest region in the immunohistochemistry market. The strong emphasis on cancer research and diagnostic advancements in Canada and the US is driving the market growth. This is primarily due to the substantial healthcare spending and well-established medical infrastructure. The widespread adoption of personalized medicine and biomarker-based testing, particularly in oncology is fueling the market growth across the region.
  • Competitive Landscape: Some of the major market players in the immunohistochemistry industry include Abcam plc, Agilent Technologies Inc., Beckman Coulter Inc. (Danaher Corporation), Becton Dickinson and Company, Bio SB Inc., Bio-Rad Laboratories Inc., Bio-Techne Corporation, Cell Signaling Technology Inc., F. Hoffmann-La Roche AG, Merck KGaA, Perkinelmer Inc. and Thermo Fisher Scientific Inc., among many others.
  • Challenges and Opportunities: The market faces various challenges in the market including high costs associated with advanced imaging systems and reagents, a lack of skilled professionals capable of interpreting complex immunohistochemical data, and strict regulatory requirements for product approvals. However, the market faces several opportunities such as the rising demand for personalized medicine and targeted therapies that rely heavily on immunohistochemical markers for effective treatment planning.

Immunohistochemistry Market Trends:

Increasing Prevalence of Chronic Diseases

The rising incidence of chronic diseases including cancer is driving the demand for accurate diagnostic and prognostic tools. Immunohistochemistry is crucial for detecting biomarkers in cancer and other diseases, thus aiding in precise diagnosis and treatment planning. According to data published by the World Health Organization (WHO), in 2022, there were an estimated 20 million new cancer cases and 9.7 million deaths. The estimated number of people who were alive within 5 years following a cancer diagnosis was 53.5 million. About 1 in 5 people develop cancer in their lifetime, and approximately 1 in 9 men and 1 in 12 women die from the disease. This surge is aptly met by the key players by introducing more effective products and services. For instance, in April 2024, Bio-Rad Laboratories, Inc., a global leader in life science research and clinical diagnostic products, announced the launch of its first ultrasensitive multiplexed digital PCR assay, the ddPLEX ESR1 Mutation Detection Kit. The assay expands the company's Droplet Digital PCR (ddPCR) offering for the oncology market, where highly sensitive and multiplexed mutation detection assays aid translational research, therapy selection, and disease monitoring. This is further expected to boost the immunohistochemistry market forecast over the coming years.

Significant Technological Advancement

The growing technological innovations in microscopy, staining techniques, and digital imaging enhance the effectiveness and efficiency of immunohistochemistry procedures, thereby making it a preferred method for detailed tissue analysis. For instance, in May 2023, BD (Becton, Dickinson, and Company), a leading global medical technology company, announced the worldwide commercial launch of a new world sales sorting instrument offering two breakthrough technologies that enable researchers to uncover more detailed information about sales that were previously invisible in traditional flow cytometry experiments. With BD CellView Image Technology, researchers can see detailed microscopic images of individual cells and sort at high speeds based on visual characteristics to confirm insights in real time. With BD SpectalFX Technology, researchers can achieve full spectrum cell sorting, coupled with expanded performance enabled by a new modular optical architecture and system-aware algorithms, to perform high parameter experiments within a simplified workflow.

Rising Focus on Personalized Medicine

The increasing shift toward personalized medicine, especially in oncology, is driving the need for immunohistochemistry to identify specific molecular targets and tailor treatments to individual patient profiles, thus improving therapeutic outcomes. For instance, in June 2023, Thermo Fisher Scientific, the world leader in serving science, announced the launch of Gibco OncoPro Tumor Roid Culture Medium Kit, the first commercially available culture medium specifically developed for the expansion of patient-derived tumoroids, or cancer organoids, from multiple cancer indications. Similarly, in January 2023, Apollo Cancer Center, Bengaluru, launched India's first AI Precision Oncology Center (POC) in a significant move that will substantially enhance the quality of oncology care. The Center will help the oncologists, patients, and caregivers to arrive at the best possible results in a time-bound manner the enormous possibilities offered by AI. This is influencing the immunohistochemistry market revenue across the globe.

Immunohistochemistry Market Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the global, regional, and country levels for 2024-2032. Our report has categorized the market based on product, application, and end-use.

Breakup by Product:

  • Antibodies
    • Primary Antibodies
    • Secondary Antibodies
  • Equipment
    • Slide Staining Systems
    • Tissue Microarrays
    • Tissue Processing Systems
    • Slide Scanners
    • Others
  • Reagents
    • Histological Stains
    • Blocking sera and Reagents
    • Chromogenic Substrates
    • Fixation Reagents
    • Stabilizers
    • Organic Solvents
    • Proteolytic Enzymes
    • Diluents
  • Kits

Antibodies accounts for the majority of the market share

The report has provided a detailed breakup and analysis of the market based on the product. This includes antibodies (primary and secondary), equipment (slide staining systems, tissue microarrays, tissue processing systems, slide scanners, and others), reagents (histological stains, blocking Sera and Reagents, chromogenic substrates, fixation reagents, stabilizers, organic solvents, proteolytic enzymes, and diluents), and kits. According to the report, Antibodies represented the largest segment.

The increasing need for disease diagnosis and research, especially cancers and infectious diseases is elevating the demand for specific antibodies. The rising innovations in antibody engineering improve specificity and sensitivity, enhancing diagnostic accuracy. The expanding biomedical research necessitates diverse antibodies for detailed cellular and molecular studies. Personalized treatment approaches require precise biomarker identification, boosting the use of targeted antibodies. For instance, in August 2023, Regeneron Pharmaceuticals, Inc. announced that the Biomedical Advanced Research and Development (BARDA)authority has agreed with Regeneron to support clinical development, clinical manufacturing, and the regulatory licensure process of on next-generation COVID-19 monoclonal antibody therapy for the prevention of SARS-CoV-2 infection.

Breakup by Application:

  • Diagnostics
    • Cancer
    • Infectious Diseases
    • Cardiovascular Diseases
    • Autoimmune Diseases
    • Diabetes Mellitus
    • Nephrological Diseases
  • Drug Testing

Diagnostics holds the largest share of the industry

A detailed breakup and analysis of the market based on the application have also been provided in the report. This includes diagnostics (cancer, infectious diseases, cardiovascular diseases, autoimmune diseases, diabetes mellitus, and nephrological diseases) and drug testing. According to the report, diagnostics accounted for the largest market share.

The increasing cases of cardiovascular, infectious diseases, cancer, autoimmune, nephrological conditions, and diabetes necessitate advanced diagnostic methods. In line with this, the enhancing focus on personalized treatment plans based on specific biomarkers detected through immunohistochemistry. Significant improvements in staining techniques and emerging technologies improve the accuracy and efficiency of disease diagnosis. The growing research activities require detailed cellular analysis, promoting the use of immunohistochemistry in understanding disease mechanisms and pathology. This is further driving the demand for diagnostics in the immunohistochemistry market growth.

Breakup by End-Use:

  • Hospitals and Diagnostic Laboratories
  • Research Institutes
  • Others

Hospitals and Diagnostic Laboratories represents the leading market segment

The report has provided a detailed breakup and analysis of the market based on the end-use. This includes hospitals and diagnostic laboratories, research institutes, and others. According to the report, hospitals and diagnostic laboratories represented the largest segment.

The rising rates of chronic diseases particularly cancers, are driving the demand for precise diagnostic tools such as immunohistochemistry to accurately identify and classify disease states. Significant innovations in digital imaging systems and staining techniques enhance the diagnostic capabilities and throughput of immunohistochemistry, making it more appealing for clinical settings. The rising focus on adherence to high quality and regulatory standards in diagnostic processes necessitates reliable techniques like immunohistochemistry. The increasing investments in healthcare infrastructure and diagnostic services boost the adoption of advanced diagnostic methods, such as immunohistochemistry, in both developed and emerging markets.

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

North America leads the market, accounting for the largest immunohistochemistry market share

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America represents the largest regional market for immunohistochemistry.

The rising cases of cancer and other chronic conditions are driving the demand for precise diagnostic methods like immunohistochemistry to identify biomarkers for effective treatment which is influencing the market growth across the region. The well-established healthcare facilities and robust funding research and development (R&D) are facilitating the adoption of advanced diagnostic technologies. According to the data from the National Library of Medicine, in 2024, 2,001,140 new cancer cases and 611,720 cancer deaths are projected to occur in the United States. Cancer mortality continued to decline through 2021, averting over 4 million deaths since 1991 because of reductions in smoking, earlier detection for some cancers, and improved treatment options in both adjuvant and metastatic settings.

Competitive Landscape:

  • The market research report has also provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the major market players in the immunohistochemistry industry include Abcam plc, Agilent Technologies Inc., Beckman Coulter Inc. (Danaher Corporation), Becton Dickinson and Company, Bio SB Inc., Bio-Rad Laboratories Inc., Bio-Techne Corporation, Cell Signaling Technology Inc., F. Hoffmann-La Roche AG, Merck KGaA, Perkinelmer Inc. and Thermo Fisher Scientific Inc.

(Please note that this is only a partial list of the key players, and the complete list is provided in the report.)

  • The market is highly competitive, with key players like Agilent Technologies, Thermo Fisher Scientific, and Roche Diagnostics dominating. These players focus on innovation and strategic partnerships to enhance their product portfolios. Other significant companies such as Merk Group, Bio-Rad Laboratories, and Danaher Corporation, emphasize expanding their global footprints through collaborations and acquisitions. In February 2023, Agilent Technologies Inc. introduced an integrated solution that combines their xCELLigence RTCA HT platform with the Bio Tek BioSpa 8 Automated Incubator. This new development offers a higher level of workflow automation, allowing further creation of label-free high throughput potency assays for immune-oncology and high throughput viral cytopathic effects (CPE) assays for the vaccine market.

Immunohistochemistry Market News:

  • In August 2023, global science and technology provider Danaher signed the definitive agreement for the acquisition of all outstanding stakes in UK-based protein consumables supplier Abcam in a deal valued at $5.7 bn.
  • In January 2024, Agilent Technologies Inc. announced an agreement with Incyte that will bring together Agilent's expertise and proven track record in the development of companion diagnostics (CDx) to support the development of commercialization of Incyte's hematology and oncology portfolio.
  • In June 2022, Merck, a leading science and technology company, announced that it has entered a collaboration with Agilent Technologies to advance Process Analytical Technologies (PAT). PAT, which is strongly encouraged by global regulatory authorities, is a key enabler for real-time release and Bioprocessing 4.0.

Key Questions Answered in This Report:

  • How has the global immunohistochemistry market performed so far, and how will it perform in the coming years?
  • What are the drivers, restraints, and opportunities in the global immunohistochemistry market?
  • What is the impact of each driver, restraint, and opportunity on the global immunohistochemistry market?
  • What are the key regional markets?
  • Which countries represent the most attractive immunohistochemistry market?
  • What is the breakup of the market based on the product?
  • Which is the most attractive product in the immunohistochemistry market?
  • What is the breakup of the market based on the application?
  • Which is the most attractive application in the immunohistochemistry market?
  • What is the breakup of the market based on the end-use?
  • Which is the most attractive end-use in the immunohistochemistry market?
  • What is the competitive structure of the market?
  • Who are the key players/companies in the global immunohistochemistry market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Immunohistochemistry Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Antibodies
    • 6.1.1 Market Trends
    • 6.1.2 Key Segments
      • 6.1.2.1 Primary Antibodies
      • 6.1.2.2 Secondary Antibodies
    • 6.1.3 Market Forecast
  • 6.2 Equipment
    • 6.2.1 Market Trends
    • 6.2.2 Key Segments
      • 6.2.2.1 Slide Staining Systems
      • 6.2.2.2 Tissue Microarrays
      • 6.2.2.3 Tissue Processing Systems
      • 6.2.2.4 Slide Scanners
      • 6.2.2.5 Others
    • 6.2.3 Market Forecast
  • 6.3 Reagents
    • 6.3.1 Market Trends
    • 6.3.2 Key Segments
      • 6.3.2.1 Histological Stains
      • 6.3.2.2 Blocking sera and Reagents
      • 6.3.2.3 Chromogenic Substrates
      • 6.3.2.4 Fixation Reagents
      • 6.3.2.5 Stabilizers
      • 6.3.2.6 Organic Solvents
      • 6.3.2.7 Proteolytic Enzymes
      • 6.3.2.8 Diluents
    • 6.3.3 Market Forecast
  • 6.4 Kits
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast

7 Market Breakup by Application

  • 7.1 Diagnostics
    • 7.1.1 Market Trends
    • 7.1.2 Key Segments
      • 7.1.2.1 Cancer
      • 7.1.2.2 Infectious Diseases
      • 7.1.2.3 Cardiovascular Diseases
      • 7.1.2.4 Autoimmune Diseases
      • 7.1.2.5 Diabetes Mellitus
      • 7.1.2.6 Nephrological Diseases
    • 7.1.3 Market Forecast
  • 7.2 Drug Testing
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast

8 Market Breakup by End Use

  • 8.1 Hospitals and Diagnostic Laboratories
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Research Institutes
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Others
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Abcam plc
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 Agilent Technologies Inc.
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
      • 14.3.2.4 SWOT Analysis
    • 14.3.3 Beckman Coulter Inc. (Danaher Corporation)
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
    • 14.3.4 Becton Dickinson and Company
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
      • 14.3.4.4 SWOT Analysis
    • 14.3.5 Bio SB Inc.
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
    • 14.3.6 Bio-Rad Laboratories Inc.
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
      • 14.3.6.4 SWOT Analysis
    • 14.3.7 Bio-Techne Corporation
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
    • 14.3.8 Cell Signaling Technology Inc.
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
    • 14.3.9 F. Hoffmann-La Roche AG
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 SWOT Analysis
    • 14.3.10 Merck KGaA
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
      • 14.3.10.4 SWOT Analysis
    • 14.3.11 Perkinelmer Inc.
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
      • 14.3.11.3 Financials
      • 14.3.11.4 SWOT Analysis
    • 14.3.12 Thermo Fisher Scientific Inc.
      • 14.3.12.1 Company Overview
      • 14.3.12.2 Product Portfolio
      • 14.3.12.3 Financials
      • 14.3.12.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Immunohistochemistry Market: Major Drivers and Challenges
  • Figure 2: Global: Immunohistochemistry Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Immunohistochemistry Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 4: Global: Immunohistochemistry Market: Breakup by Product (in %), 2023
  • Figure 5: Global: Immunohistochemistry Market: Breakup by Application (in %), 2023
  • Figure 6: Global: Immunohistochemistry Market: Breakup by End Use (in %), 2023
  • Figure 7: Global: Immunohistochemistry Market: Breakup by Region (in %), 2023
  • Figure 8: Global: Immunohistochemistry (Antibodies) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 9: Global: Immunohistochemistry (Antibodies) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 10: Global: Immunohistochemistry (Equipment) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 11: Global: Immunohistochemistry (Equipment) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 12: Global: Immunohistochemistry (Reagents) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 13: Global: Immunohistochemistry (Reagents) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 14: Global: Immunohistochemistry (Kits) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 15: Global: Immunohistochemistry (Kits) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 16: Global: Immunohistochemistry (Diagnostics) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 17: Global: Immunohistochemistry (Diagnostics) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 18: Global: Immunohistochemistry (Drug Testing) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 19: Global: Immunohistochemistry (Drug Testing) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 20: Global: Immunohistochemistry (Hospitals and Diagnostic Laboratories) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 21: Global: Immunohistochemistry (Hospitals and Diagnostic Laboratories) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 22: Global: Immunohistochemistry (Research Institutes) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 23: Global: Immunohistochemistry (Research Institutes) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 24: Global: Immunohistochemistry (Other End Uses) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 25: Global: Immunohistochemistry (Other End Uses) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 26: North America: Immunohistochemistry Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 27: North America: Immunohistochemistry Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 28: United States: Immunohistochemistry Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 29: United States: Immunohistochemistry Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 30: Canada: Immunohistochemistry Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 31: Canada: Immunohistochemistry Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 32: Asia-Pacific: Immunohistochemistry Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 33: Asia-Pacific: Immunohistochemistry Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 34: China: Immunohistochemistry Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 35: China: Immunohistochemistry Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 36: Japan: Immunohistochemistry Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 37: Japan: Immunohistochemistry Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 38: India: Immunohistochemistry Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 39: India: Immunohistochemistry Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 40: South Korea: Immunohistochemistry Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 41: South Korea: Immunohistochemistry Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 42: Australia: Immunohistochemistry Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 43: Australia: Immunohistochemistry Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 44: Indonesia: Immunohistochemistry Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 45: Indonesia: Immunohistochemistry Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 46: Others: Immunohistochemistry Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 47: Others: Immunohistochemistry Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 48: Europe: Immunohistochemistry Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 49: Europe: Immunohistochemistry Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 50: Germany: Immunohistochemistry Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 51: Germany: Immunohistochemistry Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 52: France: Immunohistochemistry Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 53: France: Immunohistochemistry Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 54: United Kingdom: Immunohistochemistry Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 55: United Kingdom: Immunohistochemistry Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 56: Italy: Immunohistochemistry Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 57: Italy: Immunohistochemistry Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 58: Spain: Immunohistochemistry Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 59: Spain: Immunohistochemistry Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 60: Russia: Immunohistochemistry Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 61: Russia: Immunohistochemistry Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 62: Others: Immunohistochemistry Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 63: Others: Immunohistochemistry Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 64: Latin America: Immunohistochemistry Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 65: Latin America: Immunohistochemistry Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 66: Brazil: Immunohistochemistry Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 67: Brazil: Immunohistochemistry Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 68: Mexico: Immunohistochemistry Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 69: Mexico: Immunohistochemistry Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 70: Others: Immunohistochemistry Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 71: Others: Immunohistochemistry Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 72: Middle East and Africa: Immunohistochemistry Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 73: Middle East and Africa: Immunohistochemistry Market: Breakup by Country (in %), 2023
  • Figure 74: Middle East and Africa: Immunohistochemistry Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 75: Global: Immunohistochemistry Industry: SWOT Analysis
  • Figure 76: Global: Immunohistochemistry Industry: Value Chain Analysis
  • Figure 77: Global: Immunohistochemistry Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Immunohistochemistry Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Immunohistochemistry Market Forecast: Breakup by Product (in Million US$), 2024-2032
  • Table 3: Global: Immunohistochemistry Market Forecast: Breakup by Application (in Million US$), 2024-2032
  • Table 4: Global: Immunohistochemistry Market Forecast: Breakup by End Use (in Million US$), 2024-2032
  • Table 5: Global: Immunohistochemistry Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 6: Global: Immunohistochemistry Market: Competitive Structure
  • Table 7: Global: Immunohistochemistry Market: Key Players